Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA.

Sood V, Unwalla H, Gupta N, Chakraborti S, Banerjea AC.

AIDS. 2007 Jan 2;21(1):31-40.

PMID:
17148965
2.
3.

Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.

Zhou C, Bahner IC, Larson GP, Zaia JA, Rossi JJ, Kohn EB.

Gene. 1994 Nov 4;149(1):33-9.

PMID:
7958986
4.
5.
6.

Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.

Sun LQ, Wang L, Gerlach WL, Symonds G.

Nucleic Acids Res. 1995 Aug 11;23(15):2909-13.

7.

High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.

Fraisier C, Irvine A, Wrighton C, Craig R, Dzierzak E.

Gene Ther. 1998 Dec;5(12):1665-76.

8.

Inhibition of HIV-1 replication by RNA targeted against the LTR region.

Puerta-Fernández E, Barroso-del Jesus A, Romero-López C, Tapia N, Martínez MA, Berzal-Herranz A.

AIDS. 2005 Jun 10;19(9):863-70.

PMID:
15905666
10.

Identification of cleavage sites in the HIV-1 TAR RNA by 10-23 and 8-17 catalytic motif containing DNA enzymes.

Chakraborti S, Banerjea AC.

Biomacromolecules. 2003 May-Jun;4(3):568-71.

PMID:
12741771
11.

Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.

Duan L, Zhu M, Ozaki I, Zhang H, Wei DL, Pomerantz RJ.

Gene Ther. 1997 Jun;4(6):533-43. Erratum in: Gene Ther 1998 Apr;5(4):570.

13.

Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication.

Caputo A, Rossi C, Bozzini R, Betti M, Grossi MP, Barbanti-Brodano G, Balboni PG.

Gene Ther. 1997 Apr;4(4):288-95.

14.
15.

Assessment of an anti-HIV-1 combination gene therapy strategy using the antisense RNA and multimeric hammerhead ribozymes.

Ramezani A, Ma XZ, Ameli M, Arora A, Joshi S.

Front Biosci. 2006 Sep 1;11:2940-8.

PMID:
16720366
16.

Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication.

Roy S, Gupta N, Subramanian N, Mondal T, Banerjea AC, Das S.

J Gen Virol. 2008 Jul;89(Pt 7):1579-86. doi: 10.1099/vir.0.83650-0.

PMID:
18559927
17.

Ribozyme gene therapy for hepatitis C virus infection.

Welch PJ, Yei S, Barber JR.

Clin Diagn Virol. 1998 Jul 15;10(2-3):163-71.

PMID:
9741642
19.

Inhibition of HIV-1 by a double transdominant fusion gene.

Aguilar-Cordova E, Chinen J, Donehower LA, Harper JW, Rice AP, Butel JS, Belmont JW.

Gene Ther. 1995 May;2(3):181-6.

PMID:
7614248
20.

Catalytic antisense RNAs produced by incorporating ribozyme cassettes into cDNA.

Tabler M, Tsagris M.

Gene. 1991 Dec 15;108(2):175-83.

PMID:
1660835

Supplemental Content

Support Center